Why the study?
This study was conducted to characterize the pneumoconiosis disease burden through DALYs, incidence, prevalence, and mortality rates from 1991 to 2023 across the United States.
Population
Individuals of all sexes and ages across all US states
Design
Database-based epidemiological trend analysis
Key result
From 1991 to 2023 in the United States, pneumoconiosis mortality fell by 51.08%, DALYs dropped by 47.12%, and incidence decreased by 23.62%, while prevalence increased by 69.34%.
Authors
Loading...
Supports sustained workplace dust controls; leaves open drivers of slower incidence declines.
Observational
Yes
While pneumoconiosis mortality and incidence have declined in the US from 1991 to 2023, prevalence has nearly doubled, indicating improved survival and accumulation of chronic cases.
Lim et al. (2026) conducted an observational in Pneumoconiosis. From 1991 to 2023 in the United States, pneumoconiosis mortality fell by 51.08%, DALYs dropped by 47.12%, and incidence decreased by 23.62%, while prevalence increased by 69.34%.